ECOG-ACRIN EA3132

Phase II Randomized Trial of Adjuvant Radiotherapy with or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)

For more information about this clinical trial, Click here.

Schema & Eligibility ECOG-ACRIN EA3132

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Phelps County Regional Medical Center, Rolla, MO
Mercy Hospital, St. Louis, MO
St. Louis Cancer & Breast Institute, St. Louis, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, Oklahoma City, OK
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call us.